From the Gemini Eye Clinic, Zlin, (Stodulka, Slovak, Sramka, Polisensky, Liska) Czech Republic; Department of Ophthalmology, Third Faculty of Medicine, Charles University, (Stodulka) Prague, Czech Republic; and Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague (Liska), Prague, Czech Republic.
J Cataract Refract Surg. 2020 Jan;46(1):40-44. doi: 10.1097/j.jcrs.0000000000000033.
To report the initial experience with a new presbyopic phakic intraocular lens (pIOL) in the correction of high myopia and presbyopia.
Gemini Eye Clinic, Zlin, Czech Republic.
Prospective cohort study.
Presbyopic eyes with moderate to high myopia were implanted with a presbyopic posterior chamber pIOL (IPCL). The visual acuities at near and distance, endothelial cell density, and ocular condition were examined 1 week, 3 months, 1 year and 2 years postoperatively.
The mean uncorrected distance visual acuity improved significantly from 1.25 logarithm of the minimum angle of resolution (logMAR) (1.15 to 1.35 95% confidence interval [CI]) to 0.11 logMAR (95% CI, 0.03 to 0.17) (P < .0001). No eye lost 1 or more lines of corrected distance visual acuity. The mean distance refraction improved significantly from -6.9 diopters (D) (range -8.6 to -5.3 D) preoperatively to -0.35 D (range -0.55 to -0.15 D, P < .0001) with less than -0.5 D residual refraction in 11 of 17 eyes. Fifteen of 17 eyes had improved uncorrected near visual acuity to J1 (Jaeger chart) at the 2-year follow-up. The near addition at the 2-year follow-up decreased from preoperatively +1.26 D (range 0.19 to 2.34 D) to +0.39 D (range 0.18 to 0.60 D). The mean endothelial cell density was reduced from 2552 cells/mm (range 2421 to 2682 cells/mm) to 2299 cells/mm (range 2108 to 2490 cells/mm) after 2 years. All patients were subjectively satisfied with the outcomes.
The new pIOL provided good visual outcomes in near and far distances in an initial case series of patients.
报告一种新型矫正高度近视和老视的有晶状体眼后房型人工晶状体（pIOL）的初步临床经验。
捷克兹林 Gemini 眼科诊所。
前瞻性队列研究。
对中高度近视的老视眼植入有晶状体眼后房型 pIOL（IPCL）。术后 1 周、3 个月、1 年和 2 年分别检查近视力和远视力、角膜内皮细胞密度和眼部情况。
平均未矫正远视力从 1.25 最小分辨角对数视力（logMAR）（1.15 至 1.35 95%置信区间[CI]）显著提高至 0.11 logMAR（95%CI，0.03 至 0.17）（P <.0001）。无 1 眼丢失 1 行或更多行远视力矫正。平均远屈光从术前-6.9 屈光度（D）（范围-8.6 至-5.3 D）显著改善至-0.35 D（范围-0.55 至-0.15 D，P <.0001），17 眼中 11 眼残留屈光度小于-0.5 D。17 眼中 15 眼在 2 年随访时未矫正近视力提高至 J1（Jager 图表）。2 年随访时近附加量从术前+1.26 D（范围 0.19 至 2.34 D）降至+0.39 D（范围 0.18 至 0.60 D）。平均角膜内皮细胞密度从术后 2 年的 2552 个/mm（范围 2421 至 2682 个/mm）降至 2299 个/mm（范围 2108 至 2490 个/mm）。所有患者对结果均主观满意。
在该患者初始系列病例中，新型 pIOL 为近距和远距视力提供了良好的结果。
